Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches
PET and PET/CT have changed the diagnostic algorithm in oncology. Health care systems
worldwide have recently approved reimbursement for PET and PET/CT for staging of non …
worldwide have recently approved reimbursement for PET and PET/CT for staging of non …
Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
N Paracha, A Abdulla, KS MacGilchrist - Health and quality of life …, 2018 - Springer
Background Health state utility values (HSUVs) are an important input to economic
evaluations and the choice of HSUV can affect the estimate of relative cost-effectiveness …
evaluations and the choice of HSUV can affect the estimate of relative cost-effectiveness …
Cost-effectiveness of osimertinib in the first-line treatment of patients with EGFR-mutated advanced non–small cell lung cancer
Importance The survival of patients with advanced non–small cell lung cancer (NSCLC) with
epidermal growth factor receptor (EGFR) gene mutations has improved substantially in the …
epidermal growth factor receptor (EGFR) gene mutations has improved substantially in the …
[HTML][HTML] The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC
Background Immune checkpoint inhibitors improve outcomes compared with chemotherapy
in lung cancer. Tumor PD-L1 receptor expression is being studied as a predictive biomarker …
in lung cancer. Tumor PD-L1 receptor expression is being studied as a predictive biomarker …
[HTML][HTML] Health-related quality of life and utility in patients with advanced non–small-cell lung cancer: a prospective cross-sectional patient survey in a real-world …
C Chouaid, J Agulnik, E Goker, GJM Herder… - Journal of thoracic …, 2013 - Elsevier
Background: Non–small-cell lung cancer (NSCLC) has a significant impact on patients'
health-related quality of life (HRQOL). This study aimed to measure health state utility values …
health-related quality of life (HRQOL). This study aimed to measure health state utility values …
Cost-effectiveness of artificial intelligence support in computed tomography-based lung cancer screening
S Ziegelmayer, M Graf, M Makowski, J Gawlitza… - Cancers, 2022 - mdpi.com
Simple Summary Lung cancer screening with low-dose CT (LDCT) has been shown to
significantly reduce cancer-related mortality and is recommended by the United States …
significantly reduce cancer-related mortality and is recommended by the United States …
[HTML][HTML] A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer
B Goulart, S Ramsey - Value in Health, 2011 - Elsevier
Objectives Bevacizumab is approved for treatment of advanced non-small cell lung cancer
(NSCLC) in combination with chemotherapy based on a 2-month median survival benefit …
(NSCLC) in combination with chemotherapy based on a 2-month median survival benefit …
Cost-effectiveness analysis of atezolizumab versus durvalumab as first-line treatment of extensive-stage small-cell lung cancer in the USA
Y Ionova, W Vuong, O Sandoval, J Fong, V Vu… - Clinical drug …, 2022 - Springer
Abstract Background and Objectives Durvalumab and atezolizumab are approved as first-
line therapy in extensive-stage small-cell lung cancer. Although cost-effectiveness analyses …
line therapy in extensive-stage small-cell lung cancer. Although cost-effectiveness analyses …
Is SABR cost-effective in oligometastatic cancer? An economic analysis of the SABR-COMET randomized trial
Purpose The phase 2 randomized study SABR-COMET demonstrated that in patients with
controlled primary tumors and 1 to 5 oligometastatic lesions, SABR was associated with …
controlled primary tumors and 1 to 5 oligometastatic lesions, SABR was associated with …
Health-related quality of life in patients surviving non-small cell lung cancer
JPC Grutters, MA Joore, EM Wiegman, JA Langendijk… - Thorax, 2010 - thorax.bmj.com
Background and aims The EuroQol 5D (EQ-5D) is a standardised instrument for measuring
health-related quality of life (HRQoL). It provides a utility score for health, and a self-rating of …
health-related quality of life (HRQoL). It provides a utility score for health, and a self-rating of …